EXPLORING NICE CRITERIA FOR CONTINUING BIOLOGIC THERAPIES IN AXIAL SPONDYLOARTHRITIS: WHAT IS A SUBOPTIMAL RESPONSE?

被引：0
|
作者：
Yahya, Fariz [1 ,2 ]
Gaffney, Karl [3 ]
Sengupta, Raj [2 ,4 ]
机构：
[1] Univ Malaya, Med, Med Ctr, Kuala Lumpur, Malaysia
[2] Royal Natl Hosp Rheumat Dis RUH Bath, Rheumatol, Bath, Avon, England
[3] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Rheumatol, Norwich, Norfolk, England
[4] Univ Bath, Pharmacol, Bath, Avon, England
来源：
RHEUMATOLOGY | 2019年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O36
引用
收藏
页码：38 / +
页数：2
相关论文
共 41 条
  • [31] The Ankylosing Spondylitis Disease Activity Score Reflects and Predicts Response to Biologic Treatment in Axial Spondyloarthritis Patients with Coexistent Fibromyalgia Compared to the Bath Ankylosing Spondylitis Disease Activity Index
    Sacks, Sarah
    Rigler, Kathryn
    Chan, Antoni
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [32] 52-Week Efficacy and Safety of Ixekizumab in Radiographic Axial Spondyloarthritis/Ankylosing Spondylitis patients naive to biologic treatments or with prior Inadequate Response/Intolerance to Tumor Necrosis Factor Inhibitors
    Karl, Gaffney
    Daniel, Aletaha
    Andrew, Bradley
    Haschemi, Nassab Mani
    Soyi, Liu-Leage
    Raphael, Micheroli
    [J]. SWISS MEDICAL WEEKLY, 2020, : 6S - 7S
  • [33] Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2
    Navarro-Compan, Victoria
    Ramiro, Sofia
    Deodhar, Atul
    Mease, Philip J.
    Rudwaleit, Martin
    de la Loge, Christine
    Fleurinck, Carmen
    Taieb, Vanessa
    Morup, Michael F.
    Massow, Ute
    Kay, Jonathan
    Magrey, Marina
    [J]. RMD OPEN, 2024, 10 (02):
  • [34] Treatment response and drug retention rates in 24 195 biologic-naive patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
    Ornbjerg, Lykke Midtboll
    Brahe, Cecilie Heegaard
    Askling, Johan
    Ciurea, Adrian
    Mann, Herman
    Onen, Fatos
    Kristianslund, Eirik Klami
    Nordstrom, Dan
    Santos, Maria Jose
    Codreanu, Catalin
    Gomez-Reino, Juan
    Rotar, Ziga
    Gudbjornsson, Bjorn
    Di Giuseppe, Daniela
    Nissen, Michael J.
    Pavelka, Karel
    Birlik, Merih
    Kvien, Tore
    Eklund, Kari Kalervo
    Barcelos, Anabela
    Ionescu, Ruxandra
    Sanchez-Piedra, Carlos
    Tomsic, Matija
    Geirsson, Arni Jon
    Loft, Anne Gitte
    van der Horst-Bruinsma, Irene
    Jones, Gareth
    Iannone, Florenzo
    Hyldstrup, Lise
    Krogh, Niels Steen
    Hetland, Merete Lund
    Ostergaard, Mikkel
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (11) : 1536 - 1544
  • [35] Short-term suboptimal response criteria for predicting long-term non-response to first-line disease modifying therapies in multiple sclerosis: A systematic review and meta-analysis
    Rio, Jordi
    Luis Ruiz-Pena, Juan
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 361 : 158 - 167
  • [36] Defining an optimal referral strategy for patients with a suspicion of axial spondyloarthritis: what is really important? Response to: 'Evaluating the ASAS recommendations for early referral of axial spondyloarthritis in patients with chronic low back pain; is one parameter present sufficient for primary care practice?' by van Hoeven et al
    Poddubnyy, Denis
    van Tubergen, Astrid
    Landewe, Robert
    Sieper, Joachim
    van der Heijde, Desiree
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (12)
  • [37] TREATMENT RESPONSE AND DRUG RETENTION RATES IN 23,956 BIOLOGIC-NAIVE PATIENTS WITH AXIAL SPONDYLOARTHRITIS INITIATING TNFI TREATMENT - ROUTINE CARE DATA FROM 12 REGISTRIES IN THE EUROSPA COLLABORATION
    Ornbjerg, Lykke
    Brahe, Cecilie Heegaard
    Loft, Anne Gitte
    Askling, Johan
    Ciurea, Adrian
    Mann, Herman
    Onen, Fatos
    Kristianslund, Eirik
    Nordstrom, Dan
    Santos, Maria Jose
    Codreanu, Catalin
    Pombo-Suarez, Manuel
    Rotar, Ziga
    Gudbjornsson, Bjorn
    Di Giuseppe, Daniela
    Nissen, Michael
    Pavelka, Karel
    Birlik, Merih
    Sexton, Joe
    Eklund, Kari
    Barcelos, Anabela
    Ionescu, Ruxandra
    Sanchez-Piedra, Carlos
    Tomsic, Matija
    Geirsson, Arni Jon
    van der Horst-Bruinsma, Irene
    Jones, Gareth T.
    Iannone, Florenzo
    Hyldstrup, Lise
    Krogh, Niels Steen
    Hetland, Merete L.
    Stergaard, Mikkel
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1408 - 1409
  • [38] ASSOCIATION OF CLINICAL RESPONSE CRITERIA AND DISEASE ACTIVITY LEVELS WITH PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED STUDIES
    Magrey, M.
    Deodhar, A.
    Mease, P. J.
    Navarro-Compan, V
    Ramiro, S.
    Fleurinck, C.
    Taieb, V
    Morup, M.
    Massow, U.
    Kay, J.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S323 - S323
  • [39] ASSOCIATION OF CLINICAL RESPONSE CRITERIA AND DISEASE ACTIVITY LEVELS WITH PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 16-WEEK RESULTS FROM TWO PHASE 3 RANDOMISED, PLACEBO-CONTROLLED STUDIES
    Magrey, M.
    Deodhar, A.
    Mease, P. J.
    Navarro-Compan, V
    Ramiro, S.
    Rudwaleit, M.
    de la Loge, C.
    Fleurinck, C.
    Taieb, V
    Morup, M. F.
    Oortgiesen, M.
    Kay, J.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S427 - S428
  • [40] ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB
    Magrey, M.
    Deodhar, A.
    Mease, P. J.
    Navarro-Compan, V.
    Ramiro, S.
    Rudwaleit, M.
    De la Loge, C.
    Fleurinck, C.
    Taieb, V.
    Morup, M.
    Oortgiesen, M.
    Kay, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1721 - 1721
12345